Joincare Pharmaceutical Group Industry Co.,Ltd. (SHSE: 600380)
Health Care · Pharmaceuticals · CN
CN¥9.90
-2.56% today · -21.1% 1Y
Joincare Pharmaceutical Group Industry Co.,Ltd. (SHSE: 600380) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.70B and employs 13,575 people.
Over the last twelve months the share price has lost 21.1%, trading between 9.08 and 12.85.
Tweenvest scores Joincare Pharmaceutical Group Industry Co.,Ltd. across four factors: quality 86/100, value 65/100, growth 15/100, dividend 42/100. Its strongest factor is quality.
600380 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.70B
- Revenue (TTM)
- $2.05B
- P/E
- 15.22
- EPS
- 0.65
- Dividend yield
- 2.17%
- Beta (5Y)
- 0.11
- 52-week high
- CN¥12.85
- 52-week low
- CN¥9.08
- Avg volume (3M)
- —
- Shares outstanding
- 1.83B
- Employees
- 13,575
- Next earnings
- —
About Joincare Pharmaceutical Group Industry Co.,Ltd.
Joincare Pharmaceutical Group Industry Co., Ltd. is a Chinese enterprise primarily focused on the comprehensive process of researching, developing, producing, and commercializing pharmaceutical and healthcare products within China. The company boasts a broad pharmaceutical portfolio that includes both Western chemical drug preparations, addressing conditions such as respiratory, gastrointestinal, anti-infection, gonadotropic, and psychiatric disorders, as well as traditional Chinese medicines (TCM), with offerings for anti-tumor and cold relief. Beyond finished drugs, Joincare supplies chemical active pharmaceutical ingredients (APIs) and intermediates. Its operations also extend into the diagnostics sector, where it provides specialized reagents and equipment, such as an autoimmunity multiple detection platform and an IgM diagnostic kit. Furthermore, the company markets a range of health and wellness products, exemplified by American ginseng tea and Jingxin menocare essence. Joincare diversifies its business by engaging in the wholesale and retail of personal care items, including skincare products, cosmetics, and various other essential goods. Its products are available in diverse formats, such as hormone tablets, oral liquid formulations, and standard tablets. Established in 1992, Joincare Pharmaceutical Group maintains its principal offices in Shenzhen, China.
- ISIN
- CNE000001816
- Founded
- 1992
- Listed since
- Jun 8, 2001
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Harbin Pharmaceutical Group Co., Ltd.SHSE: 600664 | $2.78B | CN¥7.40 | -9.09% |
| Kangmei Pharmaceutical Co., Ltd.SHSE: 600518 | $2.76B | CN¥1.34 | +0.75% |
| Piramal Pharma LimitedNSEI: PPLPHARMA | $2.73B | Rs197.97 | -5.87% |
| Acutaas Chemicals LimitedNSEI: ACUTAAS | $2.72B | Rs3,196.50 | -2.32% |
| Curaleaf Holdings, Inc.TSX: CURA | $2.64B | CA$13.50 | -5.00% |
| Liquidia CorporationNasdaqCM: LQDA | $2.51B | $28.02 | +5.02% |
| China Resources Double-Crane Pharmaceutical Co.,Ltd.SHSE: 600062 | $2.50B | CN¥16.24 | +1.18% |
| Supernus Pharmaceuticals, Inc.NasdaqGM: SUPN | $2.46B | $42.14 | -0.57% |
Figures last refreshed Oct 4, 2026.